Table 2

Clinical characteristics of subject groups (mean (SD))

Controls (n=10)CFS (n=10)MDD (n=10)
Age (y)40.5 (10.4)40.5 (9.1)38.1 (10.6)
Sex ratio (F/M)7/37/37/3
Weight (kg)73.7 (18.8)68.0 (14.1)70.7 (13.0)
NART (full scale IQ)113.5 (11.1)116.0 (8.9)115.6 (7.0)
Duration of illness (y)N/A7.1 (4.8)5.1 (6.9)
Chalder fatigue scoreN/A27.9 (4.0)14.8 (6.9)
End tidal CO2 at rest (kPa)4.8 (0.5)4.8 (0.4)4.4 (0.5)
HAD (anxiety)3.6 (1.8)5.5 (1.6)11.4 (4.8)
HAD (depression)0.6 (0.7)6.1 (2.0)9.1 (5.8)
HAD f2-150(excluding Q4)0.2 (0.4)3.5 (1.7)8.2 (5.7)
SF36 (scaled scores, (%)):
 Physical functioning96.5 (2.4)41.5 (21.7)81.0 (18.1)
 Mental health85.6 (7.8)70.8 (9.6)46.4 (24.5)
 Role physical100.0 (0.0)20.0 (36.9)45.0 (45.3)
 Bodily pain92.8 (12.0)54.0 (27.1)74.1 (21.7)
 Role emotional96.7 (10.5)86.6 (28.3)30.0 (39.9)
 General health84.4 (17.6)33.2 (14.7)45.8 (20.5)
 Social functioning96.3 (8.4)41.3 (31.3)45.0 (32.4)
 Vitality78.5 (9.1)18.0 (10.1)32.5 (19.9)
  • 2-150 HAD-f refers to depression subscale score excluding Q4 on fatigue.